Evolution of myeloid-mediated immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Richard A. Miller et al.|Nature|2024Cited by 138
Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4Marcel Arias-Badia, Lawrence Fong, Peixi Chen et al.|JCI Insight|2025Cited by 4
Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Cancer Immunology Research|2025Cited by 0
560 Identification and therapeutic target of myeloid-mediated mechanisms of immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0
463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastasesAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0